During the past decade, Diagnostic Consultation Center CONVEX EOOD conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diagnostic Consultation Center CONVEX EOOD" #1 sponsor was "Amgen" with 2 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diagnostic Consultation Center CONVEX EOOD" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Diagnostic Consultation Center CONVEX EOOD" are "Ulcerative Colitis" (6 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Dyslipidemia" (1 trials) and "Helicobacter Pylori Infection" (1 trials). Many other conditions were trialed in "Diagnostic Consultation Center CONVEX EOOD" in a lesser frequency.

Most popular intervention types in "Diagnostic Consultation Center CONVEX EOOD" are "Drug" (12 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (4 trials), "Amoxicillin" (1 trials), "Clarithromycin" (1 trials) and "EDP-938" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diagnostic Consultation Center CONVEX EOOD" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Diagnostic Consultation Center CONVEX EOOD". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Diagnostic Consultation Center CONVEX EOOD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diagnostic Consultation Center CONVEX EOOD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".